New Delhi: Over 60 percent fixed-dose combination (FDC) drugs consumed for mental health disorders in India are “unapproved” and lack therapeutic benefit, an analysis has found amid a major crackdown on …
New Delhi: Following a crackdown on 156 fixed dose combination (FDC) drugs after finding them without therapeutic justification and even unsafe in several cases, a top official in the Central Drugs Standard Control …
New Delhi: India’s apex drug regulator has given conditional approval to continue the manufacture and sale of five fixed-dose combination (FDC) medicines, asking drugmakers to produce post-marketing safety and efficacy data …